SIRT1 and inflammatory bowel disease: Similarly, NBP might be an ideal approach for sepsis, IBD, RA, cancer, and autoimmune encephalomyelitis as its ability to target HIF-1α, AMPK/SIRT1, PI3K/Ak, and Nrf-2/HO-1.